HOP S. TRAN CAO to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Xenograft Model Antitumor Assays.
Connection Strength
0.328
-
Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther. 2010 Jul; 9(7):2068-78.
Score: 0.267
-
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
Score: 0.046
-
Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Ther. 2009 Jul; 8(7):1779-86.
Score: 0.016